Immunotherapy: TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY
Saved in:
| Published in: | Cytotherapy (Oxford, England) Vol. 25; no. 6; p. S240 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
01.05.2023
|
| Subjects: | |
| ISSN: | 1465-3249 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Author | van Loenen, M Coomans, C Bisso, A Drent, E Proost, N Emami, N Meijer, M Middendorp, S Baardman, S Melief, S Gobessi, S Salcedo, E Verweij, D Throsby, M Braem, S van de Weg, S van de Ven, M Norell, H |
|---|---|
| Author_xml | – sequence: 1 fullname: Middendorp, S – sequence: 2 fullname: Drent, E – sequence: 3 fullname: Bisso, A – sequence: 4 fullname: Baardman, S – sequence: 5 fullname: Verweij, D – sequence: 6 fullname: Salcedo, E – sequence: 7 fullname: Coomans, C – sequence: 8 fullname: Braem, S – sequence: 9 fullname: van de Weg, S – sequence: 10 fullname: Meijer, M – sequence: 11 fullname: Proost, N – sequence: 12 fullname: van de Ven, M – sequence: 13 fullname: Norell, H – sequence: 14 fullname: van Loenen, M – sequence: 15 fullname: Emami, N – sequence: 16 fullname: Melief, S – sequence: 17 fullname: Gobessi, S – sequence: 18 fullname: Throsby, M |
| BookMark | eNo9kM1Kw0AURmdRwbb6CMIsFYzOZP4SF8KYpmkgppKMiqshSSfY2iYlsUKfS5-jz2TaiqsLF77D4QxAr6orA8AFRjcYYX6bYsqZRWzqXtrkCiGOqCV6oP__PgWDtl0gZCPHYX1gwtVqU9Wf76bJ1ts7qGQS-CqMAzh9kUkoY-jJxAvj6aOEr6GawGCkuvE1lHAcJqmywtjyIpmmcPe9-1FeYj3I1B9BBT0_iqCa-Il8ejsDJ2W2bM353x2C57GvvIkVTYPQk5FVdPLCMrkwMyYIIsjJ3dJ2MxeXTsZEzmnJmCtElhespK7jckrNzMmpTQpucIkEp7wgQ8CO3KKp27YxpV4381XWbDVGet9HH_rofQhtE33oo0W3uz_uTCf3NTeNLpbzal5kyw-zNe2i3jRV562xbm2NjpA9wyYHgiC_6D1rCg |
| ContentType | Journal Article |
| Copyright | International Society for Cell & Gene Therapy |
| Copyright_xml | – notice: International Society for Cell & Gene Therapy |
| DBID | AAYXX CITATION |
| DOI | 10.1016/S1465-3249(23)00604-7 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EndPage | S240 |
| ExternalDocumentID | 10_1016_S1465_3249_23_00604_7 1_s2_0_S1465324923006047 |
| GroupedDBID | --- --M .1- .FO .~1 1P~ 1~. 29F 36B 4.4 457 4G. 53G 5GY 5VS 7-5 8P~ AAAJQ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAXKI AAXUO ABDBF ABGSF ABJNI ABMAC ABMZM ABUDA ABXDB ACDAQ ACGEJ ACGFS ACRLP ACUHS ADBBV ADCVX ADEZE ADXPE AEBSH AEHWI AEIPS AEKER AENEX AEVXI AFCTW AFJKZ AFKVX AFKWA AFRHN AFTJW AFXIZ AGEKW AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AJWEG AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANKPU ANZVX ASPBG AVWKF AWYRJ AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DU5 EAP EBC EBS EFJIC EJD EMB EMK EMOBN ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN GBLVA H13 HVGLF HZ~ KOM LUGTX M44 MO0 O-L O9. OAUVE OK~ P-8 P-9 P2P PC. Q38 R2- ROL SDF SPCBC SSH SSI SSU SSZ SV3 T5K TDBHL TFW Z5R ~G- AATTM AAYWO AAYXX ACIEU ACLOT ACVFH ADCNI AEUPX AFPUW AIGII AIIUN AKBMS AKYEP APXCP CITATION EFKBS EFLBG ~HD |
| ID | FETCH-LOGICAL-c1017-eb7ed5730308b9f29a91f8a57b64f55977abc5f4989644ed8b423c6e1f07646c3 |
| ISSN | 1465-3249 |
| IngestDate | Sat Nov 29 07:02:26 EST 2025 Sun Feb 23 10:19:31 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1017-eb7ed5730308b9f29a91f8a57b64f55977abc5f4989644ed8b423c6e1f07646c3 |
| ParticipantIDs | crossref_primary_10_1016_S1465_3249_23_00604_7 elsevier_clinicalkeyesjournals_1_s2_0_S1465324923006047 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-05-00 |
| PublicationDateYYYYMMDD | 2023-05-01 |
| PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-00 |
| PublicationDecade | 2020 |
| PublicationTitle | Cytotherapy (Oxford, England) |
| PublicationYear | 2023 |
| SSID | ssj0020885 |
| Score | 2.350606 |
| SourceID | crossref elsevier |
| SourceType | Index Database Publisher |
| StartPage | S240 |
| SubjectTerms | Advanced Basic Science Other |
| Title | Immunotherapy: TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1465324923006047 |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: ScienceDirect database issn: 1465-3249 databaseCode: AIEXJ dateStart: 19990101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.sciencedirect.com omitProxy: false ssIdentifier: ssj0020885 providerName: Elsevier – providerCode: PRVAWR databaseName: Taylor and Francis Online Journals issn: 1465-3249 databaseCode: TFW dateStart: 19990101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.tandfonline.com omitProxy: false ssIdentifier: ssj0020885 providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZKxwMviKsYN_kBJlDnkXti3tI0WwNbV7Vm6luUpI6EhNKqKVP7u-Cdf7DfxHHiJM0GEiDxYrWpnbo-n8-tPl8QemWDT891KyI8NiBAcSyL0CiKiGqriRbDflLMolD41B6NnNmMjjudH1UtzOUXO8uczYYu_6uo4RoIW5TO_oW465vCBXgNQocWxA7tHwk-EBUfsq6qoHNi7uTEZyIrdX7hTgJ31PPciReMzs9AKQRs2DsZsIIhVWiJ42AyZSQYEe_UnUKM7_mv-3rRGsybkL479Qc91vNEvosN_Yk7bvm33nZdfXVBZLqpzs7Lh4XsJB7OBHlJNl-slq0M7EDQRbVKJPqAjcW1tCvgupW6lXkLbeeUoFS1hmUScOfori4ui6Al5nYV61QrWZ2kka7e3jAAZS5iWt8cfqqgpqCCd8YgdmP1qn_6fe-jSnLtSCHFIDEGojLR-1rnMmQKcy1Uwhtdb6E9zTap00V7buDPPtQxPyhxsyxwK-fTFJG9ayb5RtPfygn-2j3acXnYPXRXxirYLTF2H3V49gAdjEuy8-0hZk3tXn6ID_C4oUHfPkS8BcT3uIYhljDENQyxgCEuYXiIXdwGIb76dvW9Bh9mWIAPS_A9Qp-OfeYNiXyoB0mE9gedYPO5CXZFV5yYphqNqJo6kWnHlpEWbIhRnJipQR0KrjqfOzE4_InF1VSxLcNK9Meomy0y_gRhYz6HzwxTjcEP1ZQotlSIFyjXOU9NkPs-OqrWMlyW3C1hfahRLH4oFj_U9LBY_NDeR3a14mFVmAymlOdye-fh7-T_9J9HPkN3mt3xHHXXq6_8BbqdXK4_56uXEk4_AaFikeo |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunotherapy%3A+TARGETING+OVARIAN+CARCINOMA+WITH+GDT002%2C+A+FIRST-IN-CLASS+%CE%B3%CE%B4TCR-BASED+T+CELL+THERAPY&rft.jtitle=Cytotherapy+%28Oxford%2C+England%29&rft.au=Middendorp%2C+S&rft.au=Drent%2C+E&rft.au=Bisso%2C+A&rft.au=Baardman%2C+S&rft.date=2023-05-01&rft.issn=1465-3249&rft.volume=25&rft.issue=6&rft.spage=S240&rft.epage=S240&rft_id=info:doi/10.1016%2FS1465-3249%2823%2900604-7&rft.externalDBID=ECK1-s2.0-S1465324923006047&rft.externalDocID=1_s2_0_S1465324923006047 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F14653249%2FS1465324923X00024%2Fcov150h.gif |